Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

AM 374

😃Good
Catalog No. T68492Cas No. 86855-26-7
Alias Hexadecanesulfonyl fluoride, HDSF

AM 374 (HDSF), a fatty acid amide hydrolase (FAAH) inhibitor, demonstrates the capacity to inhibit amidase activity, boasting an IC50 value of 13 nM. This compound is potentially applicable in neurological disease research.

AM 374

AM 374

😃Good
Purity: 97.08%
Catalog No. T68492Alias Hexadecanesulfonyl fluoride, HDSFCas No. 86855-26-7
AM 374 (HDSF), a fatty acid amide hydrolase (FAAH) inhibitor, demonstrates the capacity to inhibit amidase activity, boasting an IC50 value of 13 nM. This compound is potentially applicable in neurological disease research.
Pack SizePriceUSA WarehouseGlobal WarehouseQuantity
5 mg$39-In Stock
10 mg$67In StockIn Stock
25 mg$138In StockIn Stock
50 mg$222-In Stock
100 mg$328-In Stock
1 mL x 10 mM (in DMSO)$43-In Stock
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
TargetMol
View More

Batch Information

Select Batch
Purity:97.08%
Appearance:Oil
Color:White
Contact us for more batch information

Resource Download

Product Introduction

Bioactivity
Description
AM 374 (HDSF), a fatty acid amide hydrolase (FAAH) inhibitor, demonstrates the capacity to inhibit amidase activity, boasting an IC50 value of 13 nM. This compound is potentially applicable in neurological disease research.
Targets&IC50
Amidase:13 nM
In vitro
AM 374 (0-9 nM) inhibits anandamide degradation in N18TG2 cells. [1]
In vivo
AM 374 (20 μg ; intraventricular injection, once) has no effect on lever pressing in FR5, but when used in combination with anandamide (intraperitoneal injection), it reduces lever pressing.[2]
SynonymsHexadecanesulfonyl fluoride, HDSF
Chemical Properties
Molecular Weight308.5
FormulaC16H33FO2S
Cas No.86855-26-7
SmilesCCCCCCCCCCCCCCCCS(F)(=O)=O
Storage & Solubility Information
StoragePure form: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Solubility Information
DMSO: 62.5 mg/mL (202.59 mM), Sonication is recommended.
In Vivo Formulation
10% DMSO+40% PEG300+5% Tween 80+45% Saline: 2 mg/mL (6.48 mM), Sonication is recommended.
Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions.
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM3.2415 mL16.2075 mL32.4149 mL162.0746 mL
5 mM0.6483 mL3.2415 mL6.4830 mL32.4149 mL
10 mM0.3241 mL1.6207 mL3.2415 mL16.2075 mL
20 mM0.1621 mL0.8104 mL1.6207 mL8.1037 mL
50 mM0.0648 mL0.3241 mL0.6483 mL3.2415 mL
100 mM0.0324 mL0.1621 mL0.3241 mL1.6207 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy AM 374 | purchase AM 374 | AM 374 cost | order AM 374 | AM 374 chemical structure | AM 374 in vivo | AM 374 in vitro | AM 374 formula | AM 374 molecular weight